We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BMTC
2151
DELISTED
Bryn Mawr Bank Corp
BMTC
| $3.06M | ﹤0.01% |
110,683
+6,850
| +7% | +$186K |
|
|
OSG
2152
Octave Specialty Group
OSG
$222M
| $3.04M | ﹤0.01% |
212,562
+36,168
| +21% | +$529K |
|
|
TVTY
2153
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $3.04M | ﹤0.01% |
268,562
-23,504
| -8% | -$215K |
|
2154
Clearwater Paper
CLW
$376M
| $3.02M | ﹤0.01% |
83,613
-52,323
| -38% | -$1.46M |
|
2155
Icon
ICLR
$12.7B
| $3.01M | ﹤0.01% |
17,862
-10,560
| -37% | -$1.66M |
|
2156
ORIX
IX
$43.5B
| $3M | ﹤0.01% |
243,580
-285
| -0.1% | -$3.5K |
|
2157
Chefs' Warehouse
CHEF
$4.5B
| $3M | ﹤0.01% |
220,838
+35,622
| +19% | +$492K |
|
2158
International Seaways
INSW
$4.57B
| $2.98M | ﹤0.01% |
182,141
+21,694
| +14% | +$472K |
|
|
NFBK
2159
DELISTED
Northfield Bancorp
NFBK
| $2.97M | ﹤0.01% |
258,162
+5,242
| +2% | +$56.9K |
|
2160
National Beverage
FIZZ
$3.01B
| $2.97M | ﹤0.01% |
97,434
-10,826
| -10% | -$292K |
|
2161
RadNet
RDNT
$5.69B
| $2.97M | ﹤0.01% |
187,351
+278
| +0.1% | +$4.02K |
|
2162
Century Aluminum
CENX
$5.07B
| $2.97M | ﹤0.01% |
416,925
+43,500
| +12% | +$230K |
|
2163
Matrix Service
MTRX
$335M
| $2.97M | ﹤0.01% |
305,787
-144,065
| -32% | -$1.4M |
|
2164
Varex Imaging
VREX
$523M
| $2.97M | ﹤0.01% |
196,129
-77,377
| -28% | -$1.56M |
|
2165
Simulations Plus
SLP
$371M
| $2.97M | ﹤0.01% |
49,604
-2,865
| -5% | -$126K |
|
|
HNGR
2166
DELISTED
Hanger Inc.
HNGR
| $2.97M | ﹤0.01% |
179,163
-299,763
| -63% | -$5.06M |
|
2167
Establishment Labs
ESTA
$2.28B
| $2.96M | ﹤0.01% |
158,238
+54,845
| +53% | +$933K |
|
2168
Genesco
GCO
$422M
| $2.94M | ﹤0.01% |
135,853
+6,280
| +5% | +$116K |
|
2169
CorVel
CRVL
$3.19B
| $2.94M | ﹤0.01% |
124,323
-16,233
| -12% | -$320K |
|
2170
Quanex
NX
$1.01B
| $2.93M | ﹤0.01% |
210,984
-30,678
| -13% | -$365K |
|
2171
Arcturus Therapeutics
ARCT
$211M
| $2.92M | ﹤0.01% |
+62,532
| New | +$2.16M |
|
2172
Ichor Holdings
ICHR
$2.56B
| $2.91M | ﹤0.01% |
109,590
+2,410
| +2% | +$55K |
|
2173
Ingles Markets
IMKTA
$1.67B
| $2.91M | ﹤0.01% |
67,612
+12,032
| +22% | +$488K |
|
2174
Vanguard FTSE Developed Markets ETF
VEA
$237B
| $2.91M | ﹤0.01% |
75,000
| – | – |
|
2175
Interface
TILE
$2.22B
| $2.91M | ﹤0.01% |
357,247
+285
| +0.1% | +$2.42K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.